Cargando…

Choroidal Thickness Analysis in Patients with Usher Syndrome Type 2 Using EDI OCT

To portray Usher Syndrome type 2, analyzing choroidal thickness and comparing data reported in published literature on RP and healthy subjects. Methods. 20 eyes of 10 patients with clinical signs and genetic diagnosis of Usher Syndrome type 2. Each patient underwent a complete ophthalmologic examina...

Descripción completa

Detalles Bibliográficos
Autores principales: Colombo, L., Sala, B., Montesano, G., Pierrottet, C., De Cillà, S., Maltese, P., Bertelli, M., Rossetti, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449934/
https://www.ncbi.nlm.nih.gov/pubmed/26075083
http://dx.doi.org/10.1155/2015/189140
_version_ 1782373932981026816
author Colombo, L.
Sala, B.
Montesano, G.
Pierrottet, C.
De Cillà, S.
Maltese, P.
Bertelli, M.
Rossetti, L.
author_facet Colombo, L.
Sala, B.
Montesano, G.
Pierrottet, C.
De Cillà, S.
Maltese, P.
Bertelli, M.
Rossetti, L.
author_sort Colombo, L.
collection PubMed
description To portray Usher Syndrome type 2, analyzing choroidal thickness and comparing data reported in published literature on RP and healthy subjects. Methods. 20 eyes of 10 patients with clinical signs and genetic diagnosis of Usher Syndrome type 2. Each patient underwent a complete ophthalmologic examination including Best Corrected Visual Acuity (BCVA), intraocular pressure (IOP), axial length (AL), automated visual field (VF), and EDI OCT. Both retinal and choroidal measures were measured. Statistical analysis was performed to correlate choroidal thickness with age, BCVA, IOP, AL, VF, and RT. Comparison with data about healthy people and nonsyndromic RP patients was performed. Results. Mean subfoveal choroidal thickness (SFCT) was 248.21 ± 79.88 microns. SFCT was statistically significant correlated with age (correlation coefficient −0.7248179, p < 0.01). No statistically significant correlation was found between SFCT and BCVA, IOP, AL, VF, and RT. SFCT was reduced if compared to healthy subjects (p < 0.01). No difference was found when compared to choroidal thickness from nonsyndromic RP patients (p = 0.2138). Conclusions. Our study demonstrated in vivo choroidal thickness reduction in patients with Usher Syndrome type 2. These data are important for the comprehension of mechanisms of disease and for the evaluation of therapeutic approaches.
format Online
Article
Text
id pubmed-4449934
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-44499342015-06-14 Choroidal Thickness Analysis in Patients with Usher Syndrome Type 2 Using EDI OCT Colombo, L. Sala, B. Montesano, G. Pierrottet, C. De Cillà, S. Maltese, P. Bertelli, M. Rossetti, L. J Ophthalmol Research Article To portray Usher Syndrome type 2, analyzing choroidal thickness and comparing data reported in published literature on RP and healthy subjects. Methods. 20 eyes of 10 patients with clinical signs and genetic diagnosis of Usher Syndrome type 2. Each patient underwent a complete ophthalmologic examination including Best Corrected Visual Acuity (BCVA), intraocular pressure (IOP), axial length (AL), automated visual field (VF), and EDI OCT. Both retinal and choroidal measures were measured. Statistical analysis was performed to correlate choroidal thickness with age, BCVA, IOP, AL, VF, and RT. Comparison with data about healthy people and nonsyndromic RP patients was performed. Results. Mean subfoveal choroidal thickness (SFCT) was 248.21 ± 79.88 microns. SFCT was statistically significant correlated with age (correlation coefficient −0.7248179, p < 0.01). No statistically significant correlation was found between SFCT and BCVA, IOP, AL, VF, and RT. SFCT was reduced if compared to healthy subjects (p < 0.01). No difference was found when compared to choroidal thickness from nonsyndromic RP patients (p = 0.2138). Conclusions. Our study demonstrated in vivo choroidal thickness reduction in patients with Usher Syndrome type 2. These data are important for the comprehension of mechanisms of disease and for the evaluation of therapeutic approaches. Hindawi Publishing Corporation 2015 2015-05-17 /pmc/articles/PMC4449934/ /pubmed/26075083 http://dx.doi.org/10.1155/2015/189140 Text en Copyright © 2015 L. Colombo et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Colombo, L.
Sala, B.
Montesano, G.
Pierrottet, C.
De Cillà, S.
Maltese, P.
Bertelli, M.
Rossetti, L.
Choroidal Thickness Analysis in Patients with Usher Syndrome Type 2 Using EDI OCT
title Choroidal Thickness Analysis in Patients with Usher Syndrome Type 2 Using EDI OCT
title_full Choroidal Thickness Analysis in Patients with Usher Syndrome Type 2 Using EDI OCT
title_fullStr Choroidal Thickness Analysis in Patients with Usher Syndrome Type 2 Using EDI OCT
title_full_unstemmed Choroidal Thickness Analysis in Patients with Usher Syndrome Type 2 Using EDI OCT
title_short Choroidal Thickness Analysis in Patients with Usher Syndrome Type 2 Using EDI OCT
title_sort choroidal thickness analysis in patients with usher syndrome type 2 using edi oct
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449934/
https://www.ncbi.nlm.nih.gov/pubmed/26075083
http://dx.doi.org/10.1155/2015/189140
work_keys_str_mv AT colombol choroidalthicknessanalysisinpatientswithushersyndrometype2usingedioct
AT salab choroidalthicknessanalysisinpatientswithushersyndrometype2usingedioct
AT montesanog choroidalthicknessanalysisinpatientswithushersyndrometype2usingedioct
AT pierrottetc choroidalthicknessanalysisinpatientswithushersyndrometype2usingedioct
AT decillas choroidalthicknessanalysisinpatientswithushersyndrometype2usingedioct
AT maltesep choroidalthicknessanalysisinpatientswithushersyndrometype2usingedioct
AT bertellim choroidalthicknessanalysisinpatientswithushersyndrometype2usingedioct
AT rossettil choroidalthicknessanalysisinpatientswithushersyndrometype2usingedioct